Prognostic value of PLR in various cancers: a meta-analysis

Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. We conducted a meta-analysis of published studies to evaluate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2014-06, Vol.9 (6), p.e101119-e101119
Hauptverfasser: Zhou, Xin, Du, Yiping, Huang, Zebo, Xu, Jun, Qiu, Tianzhu, Wang, Jian, Wang, Tongshan, Zhu, Wei, Liu, Ping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e101119
container_issue 6
container_start_page e101119
container_title PloS one
container_volume 9
creator Zhou, Xin
Du, Yiping
Huang, Zebo
Xu, Jun
Qiu, Tianzhu
Wang, Jian
Wang, Tongshan
Zhu, Wei
Liu, Ping
description Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. A total of 13,964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; Pheterogeneity
doi_str_mv 10.1371/journal.pone.0101119
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1540755014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A417793197</galeid><doaj_id>oai_doaj_org_article_03ae1686c240438e9509041f47a905b0</doaj_id><sourcerecordid>A417793197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c809t-7083e6471a8edf6f05b24a75bd2914a3f5c38cb9c39375b49a5a759351196ac83</originalsourceid><addsrcrecordid>eNqNkttq3DAQhk1paQ7tG5TWUCjthbeSJVlWC4UQelhYSEgPt2JWlne1eK2tZIfk7TvuOmFdclF8YXv0zT_zjyZJXlAyo0zS9xvfhxaa2c63dkYooZSqR8kxVSzPipywxwffR8lJjBtCBCuL4mlylHNVlDSnx8nHy-BXrY-dM-k1NL1NfZ1eLq5S1-J_cL6PqYHW2BA_pJBubQcZYNnb6OKz5EkNTbTPx_dp8vPL5x_n37LFxdf5-dkiMyVRXSZJyWzBJYXSVnVRE7HMOUixrHJFObBaGFaapTJMMYxyBQJPFRNoqABTstPk1V531_ioR99RU8GJFIJQjsR8T1QeNnoX3BbCrfbg9N-ADysNAS02VhMGlhZlYXJOOCutEkQRTmsuQWFnBLU-jdX65dZWxrZdgGYiOj1p3Vqv_LXGbnKZD-2-HQWC_93b2Omti8Y2DbQWxzn0jRfIJROIvv4HfdjdSK0ADbi29ljXDKL6jFMpFaNKIjV7gMKnsltncElqh_FJwrtJAjKdvelW0Meo59-v_p-9-DVl3xywawtNt46-6Tvn2zgF-R40wccYbH0_ZEr0sON309DDjutxxzHt5eEF3SfdLTX7A73e8vo</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1540755014</pqid></control><display><type>article</type><title>Prognostic value of PLR in various cancers: a meta-analysis</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Zhou, Xin ; Du, Yiping ; Huang, Zebo ; Xu, Jun ; Qiu, Tianzhu ; Wang, Jian ; Wang, Tongshan ; Zhu, Wei ; Liu, Ping</creator><creatorcontrib>Zhou, Xin ; Du, Yiping ; Huang, Zebo ; Xu, Jun ; Qiu, Tianzhu ; Wang, Jian ; Wang, Tongshan ; Zhu, Wei ; Liu, Ping</creatorcontrib><description>Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. A total of 13,964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; Pheterogeneity &lt;0.001). Subgroup analysis revealed that increased PLR was a negative prognostic marker in patients with gastric cancer (HR = 1.35, 95%CI: 0.80-2.25, Pheterogeneity = 0.011), colorectal cancer (HR = 1.65, 95%CI: 1.33-2.05, Pheterogeneity = 0.995), hepatocellular carcinoma (HR = 3.07, 95% CI: 2.04-4.62, Pheterogeneity = 0.133), ovarian cancer (HR = 1.57, 95%CI: 1.07-2.31, Pheterogeneity = 0.641) and non-small cell lung cancer (NSCLC) (HR = 1.85, 95% CI: 1.42-2.41, Pheterogeneity = 0.451) except for pancreatic cancer (HR = 1.00, 95%CI: 0.92-1.09, Pheterogeneity = 0.388). The meta-analysis demonstrated that PLR could act as a significant biomarker in the prognosis of various cancers.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0101119</identifier><identifier>PMID: 24968121</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Bioindicators ; Biology and Life Sciences ; Biomarkers ; Blood platelets ; Cancer ; Colorectal cancer ; Colorectal carcinoma ; Confidence intervals ; Ethnicity ; Gastric cancer ; Hepatocellular carcinoma ; Humans ; Inflammation ; Liver cancer ; Lung cancer ; Lung diseases ; Lymphocyte Count ; Lymphocytes ; Medical prognosis ; Medicine and Health Sciences ; Meta-analysis ; Metastasis ; Methods ; Neoplasms - blood ; Neoplasms - mortality ; Neutrophils ; Non-small cell lung cancer ; Non-small cell lung carcinoma ; Odds Ratio ; Oncology ; Ovarian cancer ; Ovarian carcinoma ; Pancreatic cancer ; Patients ; Physical Sciences ; Platelet Count ; Prognosis ; Proportional Hazards Models ; Research and Analysis Methods ; Studies ; Systematic review</subject><ispartof>PloS one, 2014-06, Vol.9 (6), p.e101119-e101119</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 Zhou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2014 Zhou et al 2014 Zhou et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c809t-7083e6471a8edf6f05b24a75bd2914a3f5c38cb9c39375b49a5a759351196ac83</citedby><cites>FETCH-LOGICAL-c809t-7083e6471a8edf6f05b24a75bd2914a3f5c38cb9c39375b49a5a759351196ac83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072728/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072728/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79569,79570</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24968121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xin</creatorcontrib><creatorcontrib>Du, Yiping</creatorcontrib><creatorcontrib>Huang, Zebo</creatorcontrib><creatorcontrib>Xu, Jun</creatorcontrib><creatorcontrib>Qiu, Tianzhu</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Wang, Tongshan</creatorcontrib><creatorcontrib>Zhu, Wei</creatorcontrib><creatorcontrib>Liu, Ping</creatorcontrib><title>Prognostic value of PLR in various cancers: a meta-analysis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. A total of 13,964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; Pheterogeneity &lt;0.001). Subgroup analysis revealed that increased PLR was a negative prognostic marker in patients with gastric cancer (HR = 1.35, 95%CI: 0.80-2.25, Pheterogeneity = 0.011), colorectal cancer (HR = 1.65, 95%CI: 1.33-2.05, Pheterogeneity = 0.995), hepatocellular carcinoma (HR = 3.07, 95% CI: 2.04-4.62, Pheterogeneity = 0.133), ovarian cancer (HR = 1.57, 95%CI: 1.07-2.31, Pheterogeneity = 0.641) and non-small cell lung cancer (NSCLC) (HR = 1.85, 95% CI: 1.42-2.41, Pheterogeneity = 0.451) except for pancreatic cancer (HR = 1.00, 95%CI: 0.92-1.09, Pheterogeneity = 0.388). The meta-analysis demonstrated that PLR could act as a significant biomarker in the prognosis of various cancers.</description><subject>Analysis</subject><subject>Bioindicators</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Blood platelets</subject><subject>Cancer</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Confidence intervals</subject><subject>Ethnicity</subject><subject>Gastric cancer</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Meta-analysis</subject><subject>Metastasis</subject><subject>Methods</subject><subject>Neoplasms - blood</subject><subject>Neoplasms - mortality</subject><subject>Neutrophils</subject><subject>Non-small cell lung cancer</subject><subject>Non-small cell lung carcinoma</subject><subject>Odds Ratio</subject><subject>Oncology</subject><subject>Ovarian cancer</subject><subject>Ovarian carcinoma</subject><subject>Pancreatic cancer</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Platelet Count</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Research and Analysis Methods</subject><subject>Studies</subject><subject>Systematic review</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkttq3DAQhk1paQ7tG5TWUCjthbeSJVlWC4UQelhYSEgPt2JWlne1eK2tZIfk7TvuOmFdclF8YXv0zT_zjyZJXlAyo0zS9xvfhxaa2c63dkYooZSqR8kxVSzPipywxwffR8lJjBtCBCuL4mlylHNVlDSnx8nHy-BXrY-dM-k1NL1NfZ1eLq5S1-J_cL6PqYHW2BA_pJBubQcZYNnb6OKz5EkNTbTPx_dp8vPL5x_n37LFxdf5-dkiMyVRXSZJyWzBJYXSVnVRE7HMOUixrHJFObBaGFaapTJMMYxyBQJPFRNoqABTstPk1V531_ioR99RU8GJFIJQjsR8T1QeNnoX3BbCrfbg9N-ADysNAS02VhMGlhZlYXJOOCutEkQRTmsuQWFnBLU-jdX65dZWxrZdgGYiOj1p3Vqv_LXGbnKZD-2-HQWC_93b2Omti8Y2DbQWxzn0jRfIJROIvv4HfdjdSK0ADbi29ljXDKL6jFMpFaNKIjV7gMKnsltncElqh_FJwrtJAjKdvelW0Meo59-v_p-9-DVl3xywawtNt46-6Tvn2zgF-R40wccYbH0_ZEr0sON309DDjutxxzHt5eEF3SfdLTX7A73e8vo</recordid><startdate>20140626</startdate><enddate>20140626</enddate><creator>Zhou, Xin</creator><creator>Du, Yiping</creator><creator>Huang, Zebo</creator><creator>Xu, Jun</creator><creator>Qiu, Tianzhu</creator><creator>Wang, Jian</creator><creator>Wang, Tongshan</creator><creator>Zhu, Wei</creator><creator>Liu, Ping</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140626</creationdate><title>Prognostic value of PLR in various cancers: a meta-analysis</title><author>Zhou, Xin ; Du, Yiping ; Huang, Zebo ; Xu, Jun ; Qiu, Tianzhu ; Wang, Jian ; Wang, Tongshan ; Zhu, Wei ; Liu, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c809t-7083e6471a8edf6f05b24a75bd2914a3f5c38cb9c39375b49a5a759351196ac83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analysis</topic><topic>Bioindicators</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Blood platelets</topic><topic>Cancer</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Confidence intervals</topic><topic>Ethnicity</topic><topic>Gastric cancer</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Meta-analysis</topic><topic>Metastasis</topic><topic>Methods</topic><topic>Neoplasms - blood</topic><topic>Neoplasms - mortality</topic><topic>Neutrophils</topic><topic>Non-small cell lung cancer</topic><topic>Non-small cell lung carcinoma</topic><topic>Odds Ratio</topic><topic>Oncology</topic><topic>Ovarian cancer</topic><topic>Ovarian carcinoma</topic><topic>Pancreatic cancer</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Platelet Count</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Research and Analysis Methods</topic><topic>Studies</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xin</creatorcontrib><creatorcontrib>Du, Yiping</creatorcontrib><creatorcontrib>Huang, Zebo</creatorcontrib><creatorcontrib>Xu, Jun</creatorcontrib><creatorcontrib>Qiu, Tianzhu</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Wang, Tongshan</creatorcontrib><creatorcontrib>Zhu, Wei</creatorcontrib><creatorcontrib>Liu, Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints in Context (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xin</au><au>Du, Yiping</au><au>Huang, Zebo</au><au>Xu, Jun</au><au>Qiu, Tianzhu</au><au>Wang, Jian</au><au>Wang, Tongshan</au><au>Zhu, Wei</au><au>Liu, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic value of PLR in various cancers: a meta-analysis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2014-06-26</date><risdate>2014</risdate><volume>9</volume><issue>6</issue><spage>e101119</spage><epage>e101119</epage><pages>e101119-e101119</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Recently, more and more studies investigated the association of inflammation parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various cancers. However, the prognostic role of PLR in cancer remains controversial. We conducted a meta-analysis of published studies to evaluate the prognostic value of PLR in various cancers. In order to investigate the association between PLR and overall survival (OS), the hazard ratio (HR) and its 95% confidence interval (CI) were calculated. A total of 13,964 patients from 26 studies were included in the analysis. The summary results showed that elevated PLR was a negative predictor for OS with HR of 1.60 (95%CI: 1.35-1.90; Pheterogeneity &lt;0.001). Subgroup analysis revealed that increased PLR was a negative prognostic marker in patients with gastric cancer (HR = 1.35, 95%CI: 0.80-2.25, Pheterogeneity = 0.011), colorectal cancer (HR = 1.65, 95%CI: 1.33-2.05, Pheterogeneity = 0.995), hepatocellular carcinoma (HR = 3.07, 95% CI: 2.04-4.62, Pheterogeneity = 0.133), ovarian cancer (HR = 1.57, 95%CI: 1.07-2.31, Pheterogeneity = 0.641) and non-small cell lung cancer (NSCLC) (HR = 1.85, 95% CI: 1.42-2.41, Pheterogeneity = 0.451) except for pancreatic cancer (HR = 1.00, 95%CI: 0.92-1.09, Pheterogeneity = 0.388). The meta-analysis demonstrated that PLR could act as a significant biomarker in the prognosis of various cancers.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24968121</pmid><doi>10.1371/journal.pone.0101119</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2014-06, Vol.9 (6), p.e101119-e101119
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1540755014
source Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Analysis
Bioindicators
Biology and Life Sciences
Biomarkers
Blood platelets
Cancer
Colorectal cancer
Colorectal carcinoma
Confidence intervals
Ethnicity
Gastric cancer
Hepatocellular carcinoma
Humans
Inflammation
Liver cancer
Lung cancer
Lung diseases
Lymphocyte Count
Lymphocytes
Medical prognosis
Medicine and Health Sciences
Meta-analysis
Metastasis
Methods
Neoplasms - blood
Neoplasms - mortality
Neutrophils
Non-small cell lung cancer
Non-small cell lung carcinoma
Odds Ratio
Oncology
Ovarian cancer
Ovarian carcinoma
Pancreatic cancer
Patients
Physical Sciences
Platelet Count
Prognosis
Proportional Hazards Models
Research and Analysis Methods
Studies
Systematic review
title Prognostic value of PLR in various cancers: a meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T11%3A50%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20value%20of%20PLR%20in%20various%20cancers:%20a%20meta-analysis&rft.jtitle=PloS%20one&rft.au=Zhou,%20Xin&rft.date=2014-06-26&rft.volume=9&rft.issue=6&rft.spage=e101119&rft.epage=e101119&rft.pages=e101119-e101119&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0101119&rft_dat=%3Cgale_plos_%3EA417793197%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1540755014&rft_id=info:pmid/24968121&rft_galeid=A417793197&rft_doaj_id=oai_doaj_org_article_03ae1686c240438e9509041f47a905b0&rfr_iscdi=true